Pharmacokinetics
Showing 9976 - 10000 of >10,000
Healthy Volunteers in Fed and Fasted State Trial in Overland Park (Dexmethylphenidate)
Completed
- Healthy Volunteers in Fed and Fasted State
-
Overland Park, KansasDr. Vince Clinical Research
Oct 18, 2022
Rheumatoid Arthritis Trial in Seoul (HL237, Placebo Oral Tablet)
Unknown status
- Rheumatoid Arthritis
- HL237
- Placebo Oral Tablet
-
Seoul, Seocho-gu, Korea, Republic ofThe Catholic University of Korea, Seoul ST. Mary's Hospital
Mar 31, 2019
Prostatic Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Prostatic Neoplasms
-
Tucson, Arizona
- +109 more
Aug 2, 2022
Breast Cancer Trial in London ([18F]GE-226)
Recruiting
- Breast Cancer
- [18F]GE-226
-
London, United KingdomImperial College Healthcare NHS Trust
Jan 3, 2023
Acute Ischemic Stroke Trial in San Francisco (Balovaptan, Placebo)
Recruiting
- Acute Ischemic Stroke
- Balovaptan
- Placebo
-
San Francisco, CaliforniaCPMC Comprehensive Stroke Care Center
Aug 10, 2022
Breastfeeding Trial in Washington (Diet soda)
Recruiting
- Breastfeeding
- Diet soda
-
Washington, District of ColumbiaThe George Washington University
May 17, 2022
NSCLC Trial in Guangzhou (pembrolizumab)
Completed
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 3, 2022
Based on Data From German Sick Funds That Looks at Costs of
Completed
- Diabetes Mellitus, Type 2
- Empagliflozin
- +3 more
-
Ingelheim am Rhein, GermanyBoehringer Ingelheim
Jan 18, 2022
Hypercholesterolemia Trial in United States (Bococizumab (PF-04950615; RN316))
Completed
- Hypercholesterolemia
- Bococizumab (PF-04950615; RN316)
-
Anaheim, California
- +5 more
Feb 14, 2019
Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,
Recruiting
- Advanced or Metastatic Solid Tumors
- CD40 ligand expressing MSLN-CAR T cells
- +2 more
-
Beijing, Beijing, ChinaKaichao Feng
Jan 19, 2023
Hepatitis C, HIV Trial in Nijmegen (Daclatasvir, Atazanavir, Ritonavir)
Completed
- Hepatitis C
- HIV
- Daclatasvir
- +3 more
-
Nijmegen, NetherlandsCRCN, Radboud University Medical Center
Dec 4, 2020
Solid Tumors Trial in Milano, Bellinzona, Chur (AZD2281, liposomal doxorubicin)
Active, not recruiting
- Solid Tumors
- AZD2281
- liposomal doxorubicin
-
Milano, Italy
- +2 more
Nov 17, 2021
First in Man Study to Evaluate Initial Safety Trial in Leeds (GL-0719, Placebo)
Recruiting
- First in Man Study to Evaluate Initial Safety
- GL-0719
- Placebo
-
Leeds, United KingdomLabcorp Clinical Research Unit Ltd
Sep 9, 2022
Childhood Nephrotic Syndrome Trial (Obinutuzumab, MMF, Prednisone)
Not yet recruiting
- Childhood Nephrotic Syndrome
- Obinutuzumab
- +5 more
- (no location specified)
Nov 23, 2022
Herpes Simplex Virus, Neonatal Sepsis Trial in Wichita, New Orleans, Durham (Acyclovir)
Completed
- Herpes Simplex Virus
- Neonatal Sepsis
-
Wichita, Kansas
- +2 more
Dec 20, 2018
Pharmacokinetics, Safety Trial in Shanghai (GV-971, Placebo)
Unknown status
- Pharmacokinetics
- Safety
- GV-971
- Placebo
-
Shanghai, Shanghai, ChinaPhase-I Clinical Research Unit at Shanghai Xuhui Center hospital
Oct 19, 2018
Type 2 Diabetes Trial in Miami (DS-1150b, Placebo)
Completed
- Type 2 Diabetes Mellitus
- DS-1150b
- Placebo
-
Miami, FloridaClinical Pharmacology of Miami, Inc.
Dec 20, 2018
Healthy, Safety Trial in Gières (SAD: APX-115, SAD: Placebo, MAD: APX-115)
Completed
- Healthy
- Safety
- SAD: APX-115
- +5 more
-
Gières, FranceEurofins Optimed
Mar 7, 2019
X-Linked Adrenoleukodystrophy Trial in Worldwide (Sobetirome (NV1205))
Withdrawn
- X-Linked Adrenoleukodystrophy
- Sobetirome (NV1205)
-
Buenos Aires, Argentina
- +12 more
Mar 6, 2019